Barriers to the use of three-month Paliperidone Palmitate formulation: a study from an Italian real-world setting

CONCLUSION: PP3M initiation was associated with an overall HRU reduction. Subjects switched to PP3M had similar HRU when compared to those who did not, suggesting similar clinical conditions in both groups.PMID:37750003 | DOI:10.1080/14737175.2023.2263650

Source: Expert Review of Neurotherapeutics - September 26, 2023 Category: Neurology Authors: Giovanna Cirnigliaro Vera Battini Rita Cafaro Giulia Mosini Simone Vanzetto Tiziano Prodi Monica Macellaro Rodolfo Leuzzi Dario Conti Carla Carnovale Bernardo Dell'Osso Source Type: research